Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,498
in 3 filings

Net −$32,498. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-11-14 Masson Kristina EVP - Business Operations Grant or award · Stock Option (Right to Buy) +80,120 80,120
2022-11-14 Masson Kristina EVP - Business Operations Grant or award · Stock Option (Right to Buy) +180,269 180,269
2022-11-14 Blume-Jensen Peter President and CEO Grant or award +934,731 1,806,588
2022-11-14 Blume-Jensen Peter President and CEO Grant or award +503,419 2,310,007
2022-11-14 Blume-Jensen Peter President and CEO Grant or award +60,090 2,370,097
2022-11-14 Blume-Jensen Peter President and CEO Grant or award +26,707 320,705
2022-11-14 Blume-Jensen Peter President and CEO Grant or award · Stock Option (Right to Buy) +180,269 180,269
2022-11-14 Blume-Jensen Peter President and CEO Grant or award · Stock Option (Right to Buy) +80,120 80,120
2022-11-14 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +35,235 35,235

Page 12 of 12 · 229 trades